Search

everythinglearnresearchcommunity

for

Search:↓

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

During the COVID-19 pandemic, Iraqi women experienced more hair loss and certain skin conditions, while contagious skin infections decreased.

The pandemic changed the types of skin conditions seen, not the number of visits.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

Children's screen time increased during the pandemic, causing various health issues.

Dilated scalp capillaries might be a sign of hair loss related to COVID-19.

COVID-19 can cause temporary hair loss due to stress and inflammation.

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Some people in Saudi Arabia experienced hair loss after the COVID-19 vaccine, more often in women and those without prior hair loss.

COVID-19 may trigger hair loss in some people.

A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.

COVID-19 can cause a type of hair loss that usually starts 3-6 months after the illness, and treatment includes stress reduction and hair care products like Minoxidil.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

COVID-19 may cause hair loss conditions like alopecia areata and telogen effluvium.

Minoxidil helps hair regrow faster in stress-related hair loss.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

During COVID-19, Iraqi women saw more hair loss and skin issues like acne due to stress, masks, and hygiene habits.

Foxp3+ Regulatory T Cells are important for immunity and tolerance, affect hair growth and wound healing, and their dysfunction can contribute to obesity-related diseases and other health issues.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Early hair loss may signal a risk for metabolic syndrome and related health issues.

Finasteride use may increase suicidality risk, especially in young men.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

COVID-19 infection may trigger alopecia areata in some patients.

Stem cell therapies, especially adipose-derived ones, show promise for treating severe COVID-19 and related conditions.

The document corrects an author's affiliation in previous articles about COVID-19 and its links to hair loss and hormones.

High-dose vitamin D3 does not improve symptoms or quality of life in COVID-19 patients after one year.